|
End-of-day quote
Shenzhen S.E.
12/11/2026
|
5-day change | 1st Jan Change | ||
| 10.82 CNY | -1.01% |
|
-2.61% | -24.65% |
| 10-29 | Cachet Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 | CI |
| 09-17 | Tongrentang Allays Competition Concerns After Cachet Stake Acquisition | MT |
| Market Cap | 3.16B 473M 426M 394M 356M 673M 44.34B 690M 4.72B 1.88B 23.75B 1.77B 1.74B 75.57B | P/E 2024 |
23.5x | P/E 2025 | 37.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.52B 378M 341M 315M 284M 538M 35.44B 551M 3.77B 1.5B 18.98B 1.42B 1.39B 60.4B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.18x |
| Free-Float |
57.75% | Yield 2024 |
1.32% | Yield 2025 | 0.8% |
| 1 day | -1.01% | ||
| 1 week | -2.61% | ||
| Current month | +0.93% | ||
| 1 month | -12.60% | ||
| 3 months | -10.87% | ||
| 6 months | -22.16% | ||
| Current year | -24.65% |
| 1 week | 10.61 |  | 11.03 |
| 1 month | 10.46 | | 12.31 |
| Current year | 10.46 | | 19.69 |
| 1 year | 10.46 | | 19.69 |
| 3 years | 9.78 | | 19.69 |
| 5 years | 9.78 | | 20.7 |
| 10 years | 9.78 | | 43.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Bin Huang
PSD | President | 55 | 12/08/2021 |
Jun Lin
PRN | Corporate Officer/Principal | 57 | 09/11/2022 |
Wei Gao
PRN | Corporate Officer/Principal | 54 | 01/12/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cui Na Jing
BRD | Director/Board Member | 42 | 24/07/2009 |
Wen Li Xu
CHM | Chairman | 60 | 15/09/2015 |
Xue Tian Dong
BRD | Director/Board Member | 37 | 15/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -2.61% | -27.43% | -27.28% | 478M | |
| +0.58% | +5.93% | +42.04% | +135.94% | 1,280B | |
| +1.05% | +4.05% | +45.76% | +91.93% | 675B | |
| +0.46% | +2.86% | +27.12% | +113.85% | 521B | |
| +1.16% | +3.83% | +40.05% | +70.35% | 386B | |
| +0.34% | +0.44% | +61.38% | +44.03% | 363B | |
| +1.12% | +0.04% | +28.16% | +58.57% | 301B | |
| +0.36% | -0.57% | +3.29% | +36.25% | 286B | |
| +0.44% | +2.12% | +39.78% | +76.25% | 253B | |
| +0.37% | +1.62% | +38.00% | +127.27% | 211B | |
| Average | +0.54% | -0.42% | +29.81% | +72.71% | 428B | |
| Weighted average by Cap. | +0.77% | +0.20% | +38.36% | +96.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 24.02B 3.6B 3.24B 3B 2.71B 5.12B 337B 5.25B 35.9B 14.31B 181B 13.5B 13.22B 575B | 19.53B 2.92B 2.64B 2.44B 2.2B 4.17B 274B 4.27B 29.19B 11.63B 147B 10.98B 10.74B 468B |
| Net income | 161M 24.07M 21.69M 20.04M 18.12M 34.27M 2.26B 35.12M 240M 95.72M 1.21B 90.32M 88.4M 3.85B | 111M 16.68M 15.04M 13.89M 12.56M 23.76M 1.56B 24.35M 166M 66.36M 838M 62.61M 61.28M 2.67B |
| Net Debt | 642M 96.22M 86.72M 80.12M 72.43M 137M 9.02B 140M 960M 383M 4.83B 361M 353M 15.38B | -634M -94.94M -85.57M -79.06M -71.47M -135M -8.9B -139M -947M -378M -4.77B -356M -349M -15.18B |
Employees
1,741
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | CN¥10.82 | -1.01% | 2,991,000 |
| 11/11/26 | CN¥10.93 | +1.20% | 4,209,597 |
| 10/11/26 | CN¥10.80 | +1.03% | 2,407,400 |
| 09/11/26 | CN¥10.69 | -0.74% | 3,367,100 |
| 06/11/26 | CN¥10.77 | -2.09% | 4,557,000 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002462 Stock
Select your edition
All financial news and data tailored to specific country editions
